s6y
Company name or ticker
Search
enGene Therapeutics Inc.
3
Duncan Jason: Initial statement of beneficial ownership of securities
Filed
Friday, November 13, 2026
Period
Nov 9, 2026
Accession number
0001552781-26-000552
Documents
ownership.xml
3
e26451_ex24.htm
EX-24
On sec.gov
Filing index
All files
Complete submission text
SGML header